Patents by Inventor Andreas Ege

Andreas Ege has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090226488
    Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Ems and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Ems in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.
    Type: Application
    Filed: May 11, 2009
    Publication date: September 10, 2009
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Gregor MEYERS, Andreas EGE, Christiane MEYER, Martina von FREYBURG
  • Patent number: 7572455
    Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Erns and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Erns in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: August 11, 2009
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Gregor Meyers, Andreas Ege, Christiane Fetzer, Martina von Freyburg
  • Publication number: 20050287171
    Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Erns and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Erns in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.
    Type: Application
    Filed: May 19, 2005
    Publication date: December 29, 2005
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Gregor Meyers, Andreas Ege, Christiane Fetzer, Martina von Freyburg